Target intelligence / Profile preview

Foot-and-mouth disease virus 3C protease (FMDV 3Cpro)

Target
FMDV 3Cpro
Molecular classification
Enzyme, Cysteine protease, Chymotrypsin-like protease
01

Overview

Foot-and-mouth disease virus 3C protease (FMDV 3Cpro) is a chymotrypsin-like cysteine protease that plays a central role in the viral life cycle by processing the viral polyprotein into mature structural and non-structural proteins (UniProt P03305; Sweeney et al., 2007). It is responsible for the majority of proteolytic cleavages required for viral replication and assembly (Grubman & Baxt, 2004). In addition to its role in viral maturation, 3Cpro cleaves essential host cell proteins, including eukaryotic initiation factor 4G (eIF4G) and histone H3, to shut down host translation and transcription, thereby facilitating viral dominance and suppressing the host's innate immune response (Strong & Belsham, 2004). Because of its high conservation across FMDV serotypes and its essentiality for viral survival, 3Cpro is considered a prime target for antiviral drug development (Wang et al., 2011). While no drugs are currently approved for clinical use in livestock, experimental inhibitors such as Rupintrivir and various Michael acceptors have demonstrated potent activity by covalently binding to the active site cysteine (Cys163), effectively halting viral propagation (Sweeney et al., 2007; Wang et al., 2011).

Other names
3C proteasePicornain 3CFMDV 3C3Cpro3C cysteine protease
02

Mechanism of action

Inhibition of the 3C cysteine protease activity, which prevents the cleavage of the viral polyprotein into functional units and blocks the suppression of host cell protein synthesis, thereby halting viral replication.

03

Biological functions

Viral polyprotein processingHost protein cleavageInhibition of host transcriptionInhibition of host translationViral replication
04

Disease associations

InfectionFoot-and-mouth disease
05

Safety considerations

Potential cross-reactivity with host cysteine proteasesRapid emergence of viral resistance mutationsSpecies-specific toxicity and pharmacokinetic challenges in livestock
06

Interacting drugs

Rupintrivir

3 more in the full profile.

07

Biomarkers

Viral RNA loadCleaved eIF4G levels3Cpro enzymatic activity

Beyond the preview

Go deeper on Foot-and-mouth disease virus 3C protease (FMDV 3Cpro).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Foot-and-mouth disease virus 3C protease (FMDV 3Cpro).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call